Evidence map›Paper›PMID 18680596›Full record

ArticleVirology journal2008

Heavily glycosylated, highly fit SIVMne variants continue to diversify and undergo selection after transmission to a new host and they elicit early antibody dependent cellular responses but delayed neutralizing antibody responses.

Dawnnica Eastman, Anne Piantadosi, Xueling Wu, Donald N Forthal, Gary Landucci, Jason T Kimata, Julie Overbaugh

Open access · goldAbstract readComparative Study
In one paragraph

Article in Virology journal, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Dawnnica EastmanDivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. dke2002@cornell.edu
Anne Piantadosi
Xueling Wu
Donald N Forthal
Gary Landucci
Jason T Kimata
Julie Overbaugh
University of California, Irvine · USBaylor College of Medicine · USFred Hutch Cancer Center · USNational Institutes of Health · USSeattle University · USUniversity of Washington · US

Funding

University of Washington Medical Scientist Training Program: MD/PhDT32GM007266 · NIGMS · UNIVERSITY OF WASHINGTON · PI HORWITZ, MARSHALL S. · 1985 to 2023
$30.4M
VENEREAL DISEASET32AI007140 · NIAID · UNIVERSITY OF WASHINGTON · PI Julia Cook Dombrowski · 1985 to 2026
$19.4M
LENTIVIRAL VARIATION AND AIDSR01AI034251 · NIAID · UNIVERSITY OF WASHINGTON · PI OVERBAUGH, JULIE M. · 1993 to 2008
$2.8M
Novel Biological Activities of Anti-Viral AntibodyR01AI052039 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI FORTHAL, DONALD N · 2002 to 2006
$1.5M
CYTOPATHOGENIC DETERMINANTS OF SIV VARIANTSF32AI009337 · NIAID · UNIVERSITY OF WASHINGTON · PI KIMATA, JASON T · 1996 to 1996
–
NIAID NIH HHS F32 AI009337NIAID NIH HHS R01 AI034251NIAID NIH HHS R01 AI052039NIAID NIH HHS R01 AI 34251NIAID NIH HHS R01 AI 52039NIAID NIH HHS T32 AI007140NIAID NIH HHS T32 AI07140NIGMS NIH HHS T32 GM007266NIGMS NIH HHS T32 GM07266
6 · The paper itself

Abstract

backgroundLentiviruses such as human and simian immunodeficiency viruses (HIV and SIV) undergo continual evolution in the host. Previous studies showed that the late-stage variants of SIV that evolve in one host replicate to significantly higher levels when transmitted to a new host. However, it is unknown whether HIVs or SIVs that have higher replication fitness are more genetically stable upon transmission to a new host. To begin to address this, we analyzed the envelope sequence variation of viruses that evolved in animals infected with variants of SIVMne that had been cloned from an index animal at different stages of infection.

resultsWe found that there was more evolution of envelope sequences from animals infected with the late-stage, highly replicating variants than in animals infected with the early-stage, lower replicating variant, despite the fact that the late virus had already diversified considerably from the early virus in the first host, prior to transmission. Many of the changes led to the addition or shift in potential-glycosylation sites-, and surprisingly, these changes emerged in some cases prior to the detection of neutralizing antibody responses, suggesting that other selection mechanisms may be important in driving virus evolution. Interestingly, these changes occurred after the development of antibody whose anti-viral function is dependent on Fc-Fcgamma receptor interactions.

conclusionSIV variants that had achieved high replication fitness and escape from neutralizing antibodies in one host continued to evolve upon transmission to a new host. Selection for viral variants with glycosylation and other envelope changes may have been driven by both neutralizing and Fcgamma receptor-mediated antibody activities.

Indexed as

Genetic VariationAmino Acid SequenceAnimalsAntibodies, ViralAntibody FormationEvolution, MolecularGlycosylationHaplorhiniImmunity, CellularMolecular Sequence DataPhylogenySelection, GeneticSequence AlignmentSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusViral Envelope ProteinsAntibodies, ViralViral Envelope Proteins

Identifiers

PMID18680596
PMCPMC2518139
OpenAlexW2106912215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.